Researchers at University of East Anglia, Imperial College NHS Healthcare Trust and Oxford Biodynamics are attempting to improve diagnosis and survival rates within black males by developing a genetic blood test to identify those at risk. At present this group are two times more likely to develop prostate cancer than their white counterparts.